Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells

Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells

Yongqing Cai,1 Jian Huang,2 Haiyan Xing,1 Bin Li,1 Ling Li,1 Xianfeng Wang,1 Dan Peng,1 Jianhong Chen1 1Department of Pharmacy, Daping Hospital and Research Institute of Surgery, Army Medical University, Chongqing 400042, China; 2Department of High Altitude Biology and Pathology, High Altitude Mili...

Full description

Bibliographic Details
Main Authors: Cai Y, Huang J, Xing H, Li B, Li L, Wang X, Peng D, Chen J
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:OncoTargets and Therapy
Subjects:
human ovarian cancer
hypoxia
chemoresisance
FPR
TLR9
Online Access:https://www.dovepress.com/contribution-of-fpr-and-tlr9-to-hypoxia-induced-chemoresistance-of-ova-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/contribution-of-fpr-and-tlr9-to-hypoxia-induced-chemoresistance-of-ova-peer-reviewed-article-OTT

Similar Items